Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Melanoma - The Untold Story

5 Self-Examination Techniques That Catch Cancer and Skin Disease Early in Just Ten Minutes a Month

Why Your Hands Are the First Line of ScreeningA 2022 study published in The Lancet Oncology found that in low- and middle-income countries, a category India still partially occupies for cancer infrastructure, over 60 percent of breast cancer cases present at stage three or four. The gap between early and…

Times Life

Two Melanomas Appeared in an Empty Eye Socket Nine Years After Surgery and Her Birthmarks May Explain Why

Nine years after her eye was eviscerated, surgeons found two separate primary melanomas in the socket. Her blue birthmarks may be the clue.

Medical Daily

The Guardian view on skin cancer: fear the heat of the sun

Editorial: With melanoma cases rising, the UK must learn from public health campaigns elsewhere

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It

Moderna, Pharvaris and AbbVie span short, mid and long-term healthcare setups, from melanoma data to a Phase 3 catalyst and 13 straight years of dividend hikes.

MarketBeat

AI skin cancer detection tools are getting better – but only for people with light skin

Imagine you’re getting out of the shower one morning and you notice a mole on your thigh that you’ve never seen before. It’s reddish brown, bumpy and surprisingly large. Is it a benign mole, or is it melanoma?

The Conversation

Chilean Scientists Report Promising Results For Skin Cancer Vaccine

A Chilean clinical trial of TRIMELVax, a vaccine made with protein from the loco sea snail, shows encouraging signs against advanced melanoma.

Latin Times

No safe tan: Why Canada’s sunburn problem keeps getting worse

Scroll through social media and you will encounter a strange vocabulary for an old impulse: “tanmaxxing,” “UV chasing” and “SPF shunning.” In some corners of the internet, sunscreen is described as toxic, while a “natural” tan is portrayed as protective.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Moderna Added 45 Billion Dollars in a Day on a Melanoma Vaccine Result with No Effect Size Disclosed

Moderna and Merck's melanoma vaccine met its Phase 3 goals, but no effect size was released, and some analysts called the market reaction excessive.

Medical Daily

Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.

Moderna's cancer treatment could treat more than just Melanoma, though the stock's momentum is already stalling. Should you still buy the dip?

Barchart

Moderna’s 177% Surge Has Investors Asking What Comes Next

Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze.

MarketBeat

Moderna, Merck's Cancer Vaccine Breakthrough Raises Hope For New Wave Of Personalized Treatments

Moderna and Merck's experimental cancer vaccine has delivered positive results in a late-stage melanoma trial, giving a major boost to personalized mRNA treatments as rivals including BioNTech and Roche pursue similar approaches.

International Business Times

Moderna's Vaccine Breakthrough Supported by AI: Musk Praises mRNA Despite 'Obvious Misuse During COVID'

Moderna and Merck's personalised mRNA vaccine shows promising Phase 3 results in melanoma treatment, potentially revolutionising cancer care with tailored immunotherapy.

International Business Times UK

$40 Trillion and Parents' Night Out

Plus: ICE chillin', Moderna-Merck melanoma advances, and more...

Reason

How does Moderna’s new melanoma vaccine work – and could it treat other cancers?

Melanoma is the most aggressive form of skin cancer causing about 2,600 deaths a year in the UK

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

A Custom mRNA Therapy Built from Each Patient's Tumor Improved Melanoma Recurrence-Free Survival in a Phase 3 Trial

Merck and Moderna say intismeran autogene plus Keytruda met its primary endpoint in a Phase 3 melanoma trial. What the topline result does and does not show.

International Business Times UK

Short Sellers Just Lost $5B on the Wrong Pharma Bet: Cancer Vaccine Sends Stock Soaring 177%

Moderna's shares surged 177% after positive cancer vaccine trial results, causing $5 billion losses for short sellers. This marks a potential shift beyond its COVID-19 vaccine business.

International Business Times UK

Moderna's Personalised Cancer Vaccine Clears Phase 3: How Soon Could Patients Receive It?

Moderna and Merck's personalised cancer vaccine shows positive Phase 3 results, reducing melanoma recurrence risk. Regulatory approval is pending, with potential market availability by 2027.

The Economic Times

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Moderna's personalized cancer vaccine shows promise for melanoma patients. This new treatment trains the immune system to target specific tumor mutations. The vaccine, combined with Keytruda, significantly reduced cancer recurrence in trials. Doctors are hopeful this approach will expand to treat many other cancer types. Further trials are…

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Moderna Stock Soars More Than 100% on Cancer Vaccine Breakthrough: What Investors Are Betting On

Moderna shares surged after its personalised mRNA cancer treatment met key Phase 3 trial endpoints in melanoma with Merck's Keytruda.

Bangkok Post

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

WASHINGTON (UNITED STATES) - US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough."

Reason

Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers

The vaccine could be available as soon as 2027.

Fortune

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring

The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

International Business Times UK

Moderna Shares Double Overnight Because a Made-to-Order mRNA Vaccine Actually Beats Skin Cancer

Moderna's personalised mRNA cancer vaccine, intismeran, significantly reduces melanoma recurrence in a Phase 3 trial, doubling the company's stock value and marking a milestone in cancer treatment.

The Conversation

How we found a new transmissible cancer in bullhead catfish

For more than a decade, anglers on Lake Memphremagog — which straddles the Québec-Vermont border — have been catching brown bullhead catfish marked with distinctive black lesions.

International Business Times

Possible Skin Cancer Vaccine Shows Promise In Late Stage Trial. Moderna Stock Skyrockets.

The late-stage clinical trial was described as a "landmark moment."

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

The Indian Council of Medical Research

the Indian Journal of Dermatology

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.